Cytomegalovirus antibody and vascular pathology in renal transplant recipients
Patricia Price1,2,3, Silvia Lee4,5,6, Jacquita Affandi4,5
1School of Biomedical Science, Curtin University, Bentley, Australia. patricia.price@curtin.edu.au.
Abstract:
Cytomegalovirus (CMV) has been linked with vascular pathology and is a common complication of renal transplantation. We addressed whether CMV seropositivity influences vascular pathology several years after transplant. Levels of CMV antibody increased with age, were higher in transplant recipients than healthy controls (P < 0.001), and correlated with vascular endothelial function measured by flow mediated-dilation of the brachial artery (FMD). However, the optimal general linear model predicting FMD included CMV seropositivity as a marginal effect (P = 0.068), with age (P = 0.013), gender (P < 0.0001), and transplantation (P < 0.0001). Other measures of the burden of CMV are being tested as CMV prophylaxis is feasible as an approach to reduce vascular disease. J. Med. Virol. 89:177-181, 2017. © 2016 Wiley Periodicals, Inc.
More Related Videos
18:48In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Related Concept Videos
Cytomegalovirus Disease
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Cell-mediated Immune Responses
